Recurrent ALK Positive Large B-Cell Lymphoma
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB18441 | Maplirpacept | 2 | Recruiting | 1 |
| DB17116 | Ontorpacept | 2 | Recruiting | 1 |
| DB09037 | Pembrolizumab | 2 | Recruiting | 1 |
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB18441 | Maplirpacept | 2 | Recruiting | 1 |
| DB17116 | Ontorpacept | 2 | Recruiting | 1 |
| DB09037 | Pembrolizumab | 2 | Recruiting | 1 |